CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update
Gilead Sciences, Inc. has proposed to acquire CymaBay for $32.50 per share in cash or a total equity value of […]
ThreeD Capital Inc. Amends Investor Relations Agreement
TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture […]
Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
MONTREAL and CHARLOTTE, N.C., Feb. 28, 2024 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical company focused on the […]
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
ROCKVILLE, Md., Feb. 28, 2024 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and […]
Marathon Digital Holdings Reports Fourth Quarter and Fiscal Year 2023 Results
– Revenues Increase 229% to a Record $388 Million in 2023– Net Income Improves to $261.2 Million, or $1.06 per Diluted Share, […]
Aimfinity Investment Corp. I Announces Eighth Extension of the Deadline for an Initial Business Combination to March 28, 2024
Wilmington, Delaware, Feb. 28, 2024 (GLOBE NEWSWIRE) — Aimfinity Investment Corp. I (the “Company” or “AIMA”) (Nasdaq: AIMAU), a special […]
UMH PROPERTIES, INC. REPORTS RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2023
FREEHOLD, NJ, Feb. 28, 2024 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE:UMH) (TASE:UMH) reported Total Income of $220.9 million for […]
Interpublic Group to Present at the 2024 Morgan Stanley Technology, Media & Telecom Conference
New York, NY, Feb. 28, 2024 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG) senior management will present at the 2024 […]
Dycom Industries, Inc. to Participate in Upcoming Investor Conferences
PALM BEACH GARDENS, Fla., Feb. 28, 2024 (GLOBE NEWSWIRE) — Dycom Industries, Inc. (NYSE: DY) today announced that the Company […]
Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development […]
